Patents by Inventor Robert J. STAGG

Robert J. STAGG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and Monitoring of Treatment with a WNT Pathway Inhibitor
    Publication number: 20190000970
    Abstract: Methods for treating diseases such as cancer comprising administering a Wnt pathway inhibitor, either alone or in combination with other anti-cancer agents, and monitoring for skeletal-related side effects and/or toxicity.
    Type: Application
    Filed: April 25, 2018
    Publication date: January 3, 2019
    Applicant: OncoMed Pharmaceuticals, Inc.
    Inventors: Jakob DUPONT, Robert J. STAGG
  • Methods and monitoring of treatment with a WNT pathway inhibitor
    Patent number: 9987357
    Abstract: Methods for treating diseases such as cancer comprising administering a Wnt pathway inhibitor, either alone or in combination with other anti-cancer agents, and monitoring for skeletal-related side effects and/or toxicity.
    Type: Grant
    Filed: May 5, 2016
    Date of Patent: June 5, 2018
    Assignee: OncoMed Pharmaceuticals, Inc.
    Inventors: Jakob Dupont, Robert J. Stagg
  • Methods and Monitoring of Treatment With A WNT Pathway Inhibitor
    Publication number: 20160346388
    Abstract: Methods for treating diseases such as cancer comprising administering a Wnt pathway inhibitor, either alone or in combination with other anti-cancer agents, and monitoring for skeletal-related side effects and/or toxicity.
    Type: Application
    Filed: May 5, 2016
    Publication date: December 1, 2016
    Inventors: Jakob DUPONT, Robert J. Stagg
  • Methods and monitoring of treatment with a Wnt pathway inhibitor
    Patent number: 9359444
    Abstract: Methods for treating diseases such as cancer comprising administering a Wnt pathway inhibitor, either alone or in combination with other anti-cancer agents, and monitoring for skeletal-related side effects and/or toxicity.
    Type: Grant
    Filed: February 3, 2014
    Date of Patent: June 7, 2016
    Assignee: OncoMed Pharmaceuticals Inc.
    Inventors: Jakob Dupont, Robert J. Stagg
  • METHODS AND MONITORING OF TREATMENT WITH A WNT PATHWAY INHIBITOR
    Publication number: 20140242078
    Abstract: Methods for treating diseases such as cancer comprising administering a Wnt pathway inhibitor, either alone or in combination with other anti-cancer agents, and monitoring for skeletal-related side effects and/or toxicity.
    Type: Application
    Filed: February 3, 2014
    Publication date: August 28, 2014
    Applicant: OncoMed Pharmaceuticals, Inc.
    Inventors: Jakob DUPONT, Robert J. STAGG